AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 528779: Cyclohexacosasiloxane, dopentacontamethyl

Chemical compound data from PubChem database. IUPAC Name: 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28,30,30,32,32,34,34,36,36,38,38,40,40,42,42,44,44,46,46,48,48,50,50,52,52-dopentacontamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47,49,51-hexacosaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28,30,32,34,36,38,40,42,44,46,48,50,52-hexacosasilacyclodopentacontane. Molecular Formula: C52H156O26Si26. Molecular Weight: 1928.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
GIS for the Advancement of Child Welfare

The webinar "GIS for the Advancement of Child Welfare" describes Geographic Information Systems (GIS) and geospatial data and how they are used in child welfare. Our speaker, Kathryn Kulbicki, a consultant to the Children's Bureau's former National Resource Center for Child Welfare Data and Technology (NRC-CWDT), discusses geographic principles necessary for understanding geographic patterns and clusters. By understanding geography, we can better understand our communities and our families. Ms. Kulbicki also highlights child welfare GIS projects from several states that have been active in the NRC-CWDT's peer-to-peer group.

Joyce Rose, consultant to ICF International, moderates the webinar.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525098: 1,3-Dichloroisopropyl isohexanoate

Chemical compound data from PubChem database. IUPAC Name: 1,2-dichloropropan-2-yl 4-methylpentanoate. Molecular Formula: C9H16Cl2O2. Molecular Weight: 227.12. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Minnesota 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Patent AT-E40095-T1: [Translated] PROCESS FOR THE HYDROTHERMAL DIGESTING OF CHEMICAL WASTE AND RESIDUES HIGH IN ANNEATED ALUMINUM OXIDES CONTENT.

A process for hydrothermally disintegrating wastes or residues having a high content of calcined aluminum oxides by reacting said wastes or residues with an aqueous sodium hydroxide solution having a concentration of sodium hydroxide of from about 20 to about 50% by weight at a temperature in the range of from about 180 DEG  to about 250 DEG  C. under a saturated steam pressure corresponding to said temperature. The sodium aluminate solution obtained is separated off and optionally filtered.
2019 National Directory of Mental Health Treatment Facilities

The National Directory of Mental Health Treatment Facilities - 2019 is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2018 National Mental Health Services Survey (N-MHSS). The information about each facility that appears in this Directory was provided by that facility in response to the 2018 N-MHSS. The N-MHSS is conducted annually by the Substance Abuse and Mental Health Services Administration (SAMHSA).The Directory is ordered alphabetically by state, by city within each state, and by facility name within each city. Each facility listing includes codes that represent the services offered and other features of the facility, including codes that indicate services for hearing impaired and non-English-speaking clients. Codes are defined in a key shown on pages v-viii. Because the services offered by a particular facility may change over time, it is always a good idea to verify the information in this Directory when contacting a facility.The Directory is also available online in a searchable format with maps showing the location of each facility. Go tohttps://findtreatment.samhsa.gov. Since the online listing is updated regularly, more current information may be available there than in this Directory.
Fluocinolone acetonide

Fluocinolone Acetonide is a prescription topical solution containing 0.01% fluocinolone acetonide, a corticosteroid that helps reduce inflammation and itching on the skin. Manufactured by Fougera Pharmaceuticals Inc., it's applied directly to affected areas for conditions like eczema or dermatitis. This information was generated using AI and is provided for informational and research purposes only.
Compound 528349: 3,4-Dichloro-1-trimethylsilyloxybenzene

Chemical compound data from PubChem database. IUPAC Name: (3,4-dichlorophenoxy)-trimethylsilane. Molecular Formula: C9H12Cl2OSi. Molecular Weight: 235.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - Table II. Babesiosis to Campylobacteriosis

NNDSS - Table II. Babesiosis to Campylobacteriosis - 2016. In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.

Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 
Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.   NP:  Nationally notifiable but not published.   Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum.
* Case counts for reporting year 2016 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. 
† Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.
Retroviral expression of a kinase-defective IGF-I receptor suppresses growth and causes apoptosis of CHO and U87 cells in-vivo

Background
          Phosphatidylinositol-3,4,5-triphosphate (PtdInsP3) signaling is elevated in many tumors due to loss of the tumor suppressor PTEN, and leads to constitutive activation of Akt, a kinase involved in cell survival. Reintroduction of PTEN in cells suppresses transformation and tumorigenicity. While this approach works in-vitro, it may prove difficult to achieve in-vivo. In this study, we investigated whether inhibition of growth factor signaling would have the same effect as re-expression of PTEN.
        
        
          Methods
          Dominant negative IGF-I receptors were expressed in CHO and U87 cells by retroviral infection. Cell proliferation, transformation and tumor formation in athymic nude mice were assessed.
        
        
          Results
          Inhibition of IGF-IR signaling in a CHO cell model system by expression of a kinase-defective IGF-IR impairs proliferation, transformation and tumor growth. Reduction in tumor growth is associated with an increase in apoptosis in-vivo. The dominant-negative IGF-IRs also prevented growth of U87 PTEN-negative glioblastoma cells when injected into nude mice. Injection of an IGF-IR blocking antibody αIR3 into mice harboring parental U87 tumors inhibits tumor growth and increases apoptosis.
        
        
          Conclusion
          Inhibition of an upstream growth factor signal prevents tumor growth of the U87 PTEN-deficient glioma to the same extent as re-introduction of PTEN. This result suggests that growth factor receptor inhibition may be an effective alternative therapy for PTEN-deficient tumors.
Patent AT-E400637-T1: [Translated] DETERGENT COMPOSITION CONTAINING MONO-ANIONIC SURFACTANT

A laundry detergent composition comprising from about 0.1 % to about 80%, by weight of the composition, of a polyamine mono-anionic surfactant; and a solubiliser; in a defined weight ratio. Also, a process of making the polyamine mono-anionic surfactant and the laundry compositions containing the same.
Court and Child Welfare Data Exchange: Better Information for Improved Outcomes

This webinar described the Court Improvement Program (CIP) and featured project leaders from Georgia and Washington sharing how their states have built court data exchanges that improved child welfare and court outcomes. This webinar session provided an overview of the CIP program, explored opportunities for collaboration between child welfare information systems project managers and court improvement program directors, provided an overview of the child welfare information exchange model, and concluded with state panelists sharing their experiences.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 528292: 1,4,5-Trimethyl-2-n-Propylbenzene

Chemical compound data from PubChem database. IUPAC Name: 1,2,4-trimethyl-5-propylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Effects of Crystalline Silica Inhalation in a High-Fat Western Diet

Adipose tissue (AT), an endocrine organ, plays a central role in maintenance of whole-body energy homeostasis through its release of adipokines. Obesity, affecting over 40% of American adults, disrupts adipocyte metabolism leading to chronic systemic inflammation and metabolic dysfunction (MetDys). MetDys is associated with impaired lung function, pulmonary hypertension, and asthma. The aim of this study was to investigate the effects of silica inhalation in a pre-existing MetDys animal model to determine if an occupational exposure of silica dust has the potential to initiate or further the progression of MetDys associated conditions.
Patent AT-E401468-T1: [Translated] SHOWER WITH PERISTALTIC PUMP FOR PUMPING WATER DOWN THE DRAIN

The present invention provides a shower installation comprising a shower tray (1), in which water is drawn from the shower tray by a peristaltic pump (7) and discharged to drain. In one embodiment, water collects in a sump (4) in the floor (2) of the shower tray, and is withdrawn from the sump by a suction pipe (5) connected to an inlet port (6) of the peristaltic pump.
Commercial Medical Insurance (MSCANCC) - Vision and Eye Health Surveillance

2016. This dataset is a de-identified summary table of prevalence rates for vision and eye health data indicators from the 2016 MarketScan® Commercial Claims and Encounters Data (CCAE) is produced by Truven Health Analytics, a division of IBM Watson Health.  The CCEA data contain a convenience sample of insurance claims information from person with employer-sponsored insurance and their dependents, including 43.6 million person years of data. Prevalence estimates are stratified by all available combinations of age group, gender, and state.  Detailed information on VEHSS MarketScan analyses can be found on the VEHSS MarketScan webpage (cdc.gov/visionhealth/vehss/data/claims/marketscan.html). Information on available Medicare claims data can be found on the IBM MarketScan website (https://marketscan.truvenhealth.com). The VEHSS MarketScan summary dataset was last updated November 2019.
The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database For Osteoporosis and Osteopenia (CANDOO)

Background
          The identification of new methods of evaluating patients with osteoporotic fracture should focus on their usefulness in clinical situations such that they are easily measured and applicable to all patients. Thus, the purpose of this study was to examine the association between iliocostal distance and vertebral and non-vertebral fractures in patients seen in a clinical setting.
        
        
          Methods
          Patient data were obtained from the Canadian Database of Osteoporosis and Osteopenia (CANDOO). A total of 549 patients including 508 women and 41 men participated in this cross-sectional study. There were 142 women and 18 men with prevalent vertebral fractures, and 185 women and 21 men with prevalent non-vertebral fractures.
        
        
          Results
          In women multivariable regression analysis showed that iliocostal distance was negatively associated with the number of vertebral fractures (-0.18, CI: -0.27, -0.09; adjusted for bone mineral density at the Ward's triangle, epilepsy, cerebrovascular disease, inflammatory bowel disease, etidronate use, and calcium supplement use) and for the number of non-vertebral fractures (-0.09, CI: -0.15, -0.03; adjusted for bone mineral density at the trochanter, cerebrovascular disease, inflammatory bowel disease, and etidronate use). However, in men, multivariable regression analysis did not demonstrate a significant association between iliocostal distance and the number of vertebral and non-vertebral fractures.
        
        
          Conclusions
          The examination of iliocostal distance may be a useful clinical tool for assessment of the possibility of vertebral fractures. The identification of high-risk patients is important to effectively use the growing number of available osteoporosis therapies.
Independent predictors of breastfeeding intention in a disadvantaged population of pregnant women

Background
          Breastfeeding rates in Scotland are very low, particularly in the more disadvantaged areas. Despite a number of interventions to promote breastfeeding very few women actually intend to breastfeed their baby. The aim of this study was to identify personal and social factors independently associated with intention to breastfeed.
        
        
          Methods
          Nine hundred and ninety seven women from two socio-economically disadvantaged housing estates located on the outskirts of Glasgow participated in a study that aimed to increase the prevalence of breastfeeding. Self-administered questionnaires completed by each participant collected information in early pregnancy, prior to exposure to the study intervention, on feeding intention, previous feeding experience and socio-demographic data.
        
        
          Results
          Five factors were independently predictive of breastfeeding intention. These were previous breastfeeding experience, living with a partner, smoking, parity and maternal age. After adjusting for these five factors, neither deprivation nor receipt of milk tokens provided useful additional predictive information.
        
        
          Conclusion
          In this population of socially disadvantaged pregnant women we identified five variables that were independently predictive of breastfeeding intention. These variables could be useful in identifying women at greatest risk of choosing not to breastfeed. Appropriate promotional efforts could then be designed to give due consideration to individual circumstances.
Patent AT-E400609-T1: [Translated] FLAME RETARDANT COMPOSITIONS AND USE THEREOF

Disclosed are flame retardant compositions comprised of (a) brominated anionic styrenic polymer, and (b) at least one polybrominated alpha-omega diphenylalkane having a total of at least 6 bromine atoms directly bonded to the phenyl rings and in the range of 1 to 6 carbon atoms in the alkylene group disposed between the phenyl groups, and specified flame retarded polymer compositions with which have been blended (a) and (b) individually or in combination.
Patent AT-E400451-T1: [Translated] VALUE AND SECURITY DOCUMENT AND METHOD FOR PRODUCING IT

The document has two sheets (3) fixed to one another in a book form using a seam (5). One part of the document is arranged above and/or inside the seam and other part of the document is arranged above the former part and/or inside part of adjacent area of the sheet that is arranged inside the seam. Security information stems from the parts of the document. The sheet arranged under the seam consists of plastic or cotton material. An independent claim is also included for a procedure for the production of valuable and security documents.
Voluntary Cooperative Information System (VCIS) Multi-Year File (1982-1995)

The Voluntary Cooperative Information System (VCIS) compiled aggregate information about children who experienced substitute care in the United States between 1982 and 1995. Substitute care data were collected voluntarily by the American Public Welfare Association (APWA) from state agencies administering public child welfare programs. VCIS data are annual state-level counts of children entering, in, and exiting substitute care, tabulated by various child attributes such as age, sex, race/ethnicity, or duration of care. The VCIS therefore provides a basis for both cross-sectional and longitudinal state-level analysis, including through linkage to aggregated data from its successor, the Adoption and Foster Care Reporting and Analysis System (AFCARS).

Investigators: Original Investigator(s): American Public Human Service Association (APHSA)
(Formerly American Public Welfare Association (APWA))
Secondary Investigators:Alexander F. Roehrkasse, Ph.D. - 
Duke University
Chiara Fontaine - 
Cornell University
LeAnn McDowall - 
Cornell University
Sarah Sernaker, M.S. - 
Duke University
Clayton C. Covington, B.A.
- Duke University
2011 CMHS Uniform Reporting System (URS) Output Tables for Illinois

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 526376: 1,2,8,9-Tetrabromo-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1,2,8,9-tetrabromodibenzo-p-dioxin. Molecular Formula: C12H4Br4O2. Molecular Weight: 499.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hydrolyzed Vegetable Protein Containing Products Recalls

This list includes products subject to recall in the United States since February 2010 related to hydrolyzed vegetable protein (HVP) paste and powder distributed by Basic Food Flavors, Inc. HVP is a flavor enhancer used in a wide variety of processed food products such as soups, sauces, chilis, stews, hot dogs, gravies, seasoned snack foods, dips, and dressings.
Compound 526841: 9-Hydroxy-heptadecanoic acid, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 9-[tert-butyl(dimethyl)silyl]oxyheptadecanoate. Molecular Formula: C24H50O3Si. Molecular Weight: 414.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528011: 4-Penten-2-yl 3,5-dinitrobenzoate

Chemical compound data from PubChem database. IUPAC Name: pent-4-en-2-yl 3,5-dinitrobenzoate. Molecular Formula: C12H12N2O6. Molecular Weight: 280.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hyperbilirubinaemia after major thoracic surgery: comparison between open-heart surgery and oesophagectomy

Background:
          Hyperbilirubinaemia is a common occurrence in patients who are admitted to intensive care units (ICUs) after major surgery, and it is associated with high mortality. We investigated the incidence of hyperbilirubinaemia after two major types of thoracic surgery: open-heart surgery and oesophagectomy. In order to identify the risk factors associated with hyperbilirubinaemia after major surgery, we compared the incidence after open-heart surgery with that after oesophagectomy.
        
        
          Results:
          Hyperbilirubinaemia was detected in 51% of the open-heart surgery patients (n = 133) and in 64% in the oesophagectomy group (n = 74). The incidence of hyperbilirubinaemia was significantly related to the duration of surgery (P< 0.05). In the open-heart surgery group, duration of surgery was 465 ± 24 min for the patients without hyperbilirubinaemia and 571 ± 26 min for the patients with hyperbilirubinaemia. In the oesophagectomy group, the procedure durations were 415 ± 17 min and 493 ± 20 min, respectively. The overall mortality rate was 8% in the open-heart surgery group; the rate was 12% in those with hyperbilirubinaemia, but 5% in those without hyperbilirubinaemia. No members of the oesophagectomy group died, with or without hyperbilirubinaemia. Infection significantly affected both the occurrence of hyperbilirubinaemia and mortality in the open-heart surgery group. In the subgroups from the open-heart surgery group, 5% (three out of 65) of those without hyperbilirubinaemia (or evidence of infection) died; of the patients with hyperbilirubinaemia, 3% (one out of 38) of those without infection died and 23% (seven out of 30) with detected infection died.
        
        
          Conclusion:
          After open-heart surgery and oesophagectomy, approximately half of the patients studied had higher levels of serum total bilirubin. Time spent in surgery was significantly related to the occurrence of hyperbilirubinaemia. Infection significantly affected mortality and total bilirubin levels after open-heart surgery. Control of infection plays a crucial role in the prevention of hyperbilirubinaemia and in reducing mortality.